NT0102

· Neos Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NT0102, covering 2018-01-17 to 2018-01-17. Get the full timeline:

Most recent: Clinical Trial Update: NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]